Stock Price & Analysis

Buy MET stock as it has a "Strong Buy" analyst consensus with a $96.69 price target and shows positive momentum.

MET stock is predicted to reach $96 in 2025, supported by its Fibonacci R2 level of $84.41 and strong analyst consensus. The stock has shown positive momentum, trading above its 50-day and 200-day moving averages, with a current price of $84.02. Analysts maintain a "Strong Buy" rating with a mean price target of $96.69, indicating confidence in its growth potential.

The S1 support level for MET Stock is $79.13 ,The R1 resistant level for MET Stock is $84.46.

As of the end of day on 2025-04-01, the price of MET Stock was $81.

The target price for MET Stock according to analyst rating is 98.09, with the highest price target at 109.00 and the lowest at 88.00. Analysts have a Strong Buy rating on MET Stock overall.

The market cap of MET is $55.3B.

Meta may be overvalued due to its high P/E ratio of 26.4 and EV/EBITDA of 18.01, which exceed industry averages. Its market cap of $1.5 trillion reflects premium valuations despite mixed analyst sentiment. Recent price trends show stability near $627, but high expectations for AI-driven growth may not justify current levels. The stock's valuation metrics suggest caution, as its price-to-sales ratio of 9.6 indicates a rich multiple. Overall, Meta's valuation appears stretched compared to historical norms and industry peers.

MetLife, Inc. is a financial services company. The Company is engaged in providing insurance, annuities, employee benefits and asset management for individual and institutional customers. The Company operates through six segments: Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its Group Benefits segment offers life insurance, dental, group short- and long-term disability, individual disability, accidental death and dismemberment (AD&D) insurance, vision, and accident and health insurance, as well as prepaid legal plans and pet insurance. It also sells administrative services-only (ASO) arrangements to some employers. Its RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products.

The price prediction for MET stock by 2030 is expected to reach $120-$140. This forecast is based on the company's strong position in the insurance market, positive analyst sentiment with a consensus "Strong Buy" rating, and an average price target of $98.18, suggesting significant upside potential. The prediction also considers MetLife's execution of its New Frontier strategy and favorable macroeconomic conditions.

MET has a total of 45000 employees.